Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Effective, holistic, science-backed targeted solutions for symptomatic treatment
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
New Phase II data show vast majority of patients experiencing no relapses or disability progression
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq® Extended-Release Tablets, 50 mg of Astellas Pharma Global Development
Subscribe To Our Newsletter & Stay Updated
